As we move through 2026, the global life sciences sector is experiencing a profound technological rebirth. The Manufacturing Execution System Life Science Market analysis indicates that the market has surpassed a valuation of USD 5.3 billion, driven by the high-stakes shift toward personalized medicine and the "Pharma 4.0" initiative. In this environment, an MES is no longer just a digital...